Canada Markets closed

Why Shares of ImmunoGen Jumped 20.3% in December

·2 min read
Why Shares of ImmunoGen Jumped 20.3% in December
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The biotech company that focuses on oncology drugs released news from a positive clinical trial regarding its lead drug.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting